Pfizer Inc. [NYSE: PFE] stock went on a downward path that fall over -2.00% on Friday, amounting to a one-week price decrease of less than -9.39%. The company report on April 19, 2022 that Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28.
Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-only 2022 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 28, 2022. We have designed the virtual Annual Meeting to ensure that our shareholders who attend the virtual-only Annual Meeting will be afforded comparable rights and opportunities to participate as they would at an in-person meeting.
Beginning today, shareholders can find additional information on accessing and registering for the virtual meeting at www.meetnow.global/MWPVZT2. On the day of the Annual Meeting, shareholders may begin logging into the virtual meeting platform at 8:45 a.m. EDT using either the control number found on their proxy card, voting instruction form or the notice that was previously received. Only shareholders who log into the meeting using a control number will have the ability to ask questions or vote during the live meeting.
Over the last 12 months, PFE stock rose by 24.50%. The one-year Pfizer Inc. stock forecast points to a potential upside of 20.17.
The market cap for the stock reached $280.98 billion, with 5.61 billion shares outstanding and 5.61 billion shares in the current float. Compared to the average trading volume of 31.06M shares, PFE stock reached a trading volume of 22140774 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Pfizer Inc. [PFE]:
Morgan Stanley have made an estimate for Pfizer Inc. shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on April 06, 2022. While these analysts kept the previous recommendation, BofA Securities raised their target price from $59 to $70. The new note on the price target was released on January 05, 2022, representing the official price target for Pfizer Inc. stock. Previously, the target price had yet another raise from $44 to $65, while Bernstein kept a Mkt Perform rating on PFE stock. On December 20, 2021, analysts increased their price target for PFE shares from 56 to 70.
The Average True Range (ATR) for Pfizer Inc. is set at 1.43, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 3.46. The Price to Book ratio for the last quarter was 3.50, with the Price to Cash per share for the same quarter was set at 5.32. Price to Free Cash Flow for PFE in the course of the last twelve months was 13.29 with Quick ratio for the last quarter at 1.20.
PFE Stock Performance Analysis:
Pfizer Inc. [PFE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.39. With this latest performance, PFE shares dropped by -7.78% in over the last four-week period, additionally plugging by 12.30% over the last 6 months – not to mention a rise of 24.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PFE stock in for the last two-week period is set at 32.83, with the RSI for the last a single of trading hit 24.00, and the three-weeks RSI is set at 38.10 for Pfizer Inc. [PFE]. The present Moving Average for the last 50 days of trading for this stock 50.74, while it was recorded at 49.80 for the last single week of trading, and 49.03 for the last 200 days.
Insight into Pfizer Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Pfizer Inc. [PFE] shares currently have an operating margin of +25.58 and a Gross Margin at +57.67. Pfizer Inc.’s Net Margin is presently recorded at +27.57.
Return on Equity for this stock inclined to 31.92, with Return on Assets sitting at 13.35.
Pfizer Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.40.
PFE Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc. go to 3.13%.
Pfizer Inc. [PFE] Insider Position Details
There are presently around $181,752 million, or 68.20% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 465,274,925, which is approximately 1.159% of the company’s market cap and around 0.04% of the total institutional ownership; BLACKROCK INC., holding 409,985,644 shares of the stock with an approximate value of $19.73 billion in PFE stocks shares; and STATE STREET CORP, currently with $13.71 billion in PFE stock with ownership of nearly 1.792% of the company’s market capitalization.
Positions in Pfizer Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 1,701 institutional holders increased their position in Pfizer Inc. [NYSE:PFE] by around 192,672,547 shares. Additionally, 1,331 investors decreased positions by around 131,618,852 shares, while 271 investors held positions by with 3,451,976,406 shares. The mentioned changes placed institutional holdings at 3,776,267,805 shares, according to the latest SEC report filing. PFE stock had 429 new institutional investments in for a total of 57,897,928 shares, while 102 institutional investors sold positions of 17,695,781 shares during the same period.